Transaction DateRecipientSharesTypePriceValue
14th October 2020Michelle Renee Griffin7,351Open or private sale$53.07$390,117.57
14th October 2020Michelle Renee Griffin12,000Exercise of derivative$7.80$93,600.00
14th October 2020Michelle Renee Griffin4,649Open or private sale$52.48$243,979.52
30th September 2020Byron Lawson350Payment by withholding$0.33$115.50
30th September 2020Tim B Johnson1,630Payment by withholding$0.33$537.90
30th September 2020Shaun D Mc Means461Payment by withholding$0.33$152.13
30th September 2020John L Lubniewski921Payment by withholding$0.33$303.93
30th June 2020Tim B Johnson1,630Payment by withholding$0.72$1,173.60
30th June 2020Shaun D Mc Means447Payment by withholding$0.72$321.84
30th June 2020Byron Lawson350Payment by withholding$0.72$252.00
Htg Molecular Diagnostics
Htg Molecular Diagnostics logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

HTG Molecular Diagnostics, Inc. provides molecular technology solutions that facilitates molecular profiling. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

Ticker: HTGM
Sector: Healthcare
Industry: Diagnostics & Research
SEC Central Index Key (CIK): 1169987
Employees: 107
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags